Well made-up IPOs
The IPOs of Douglas and Galderma are hoped to mark the start of a comeback for IPOs. If this is to succeed, however, it will require substantial discounts on the valuation of the competitors already listed.
mehrEditorialGoing Public in 2024
von Christoph Ruhkamp